Search

Type

Audience

Category

Issue

Last updated

Recall class

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.

Displaying 1 - 15 of 20 items.

Health alert or recall Sodium Chloride Inj; Glass particles
The affected lots may contain glass particles.
RecallHealth product recall | 2022-08-02
Health alert or recall Red Woody & Go-Rilla - Undeclared prescription drug sildenafil.
All lots contain an undeclared ingredient (sildenafil) that is listed on the prescription drug list.
RecallHealth product recall | 2022-06-01
Health alert or recall Distribution of EVUSHELD (tixagevimab and cilgavimab for injection) with English-Only Vial and Carton Labels
EVUSHELD (tixagevimab and cilgavimab for injection) was authorized by Health Canada on April 14, 2022. In order to provide rapid access to EVUSHELD in the context of the global COVID-19 pandemic, AstraZeneca will distribute product vials and cartons with…
AlertHealth professional risk communication | 2022-04-14
Health alert or recall Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter
UPDATED INFORMATION – May 6, 2022 Further to the communication below, issued on March 15, 2022, regarding the potential for the presence of particulate matter in vials of Sodium Acetate Injection, USP (DIN 02139529) from lot 6126554, Fresenius Kabi…
AlertHealth professional risk communication | 2022-03-15
Health alert or recall RUZURGI (amifampridine) - Removal from Canadian Market: Options for Continued Treatment for Lambert-Eaton Myasthenic Syndrome
UPDATED INFORMATION - March 11, 2022 On March 10, 2022, for the second time, the Federal Court set aside Health Canada’s decision to authorize RUZURGI (amifampridine), and the second Notice of Compliance (NOC) that had been issued on June 24, 2021…
AlertHealth professional risk communication | 2022-03-11
Health alert or recall 0.9% Sodium Chloride Injection, USP and Lactated Ringer’s Injection, USP - Potential Leak During Pressure Infusion
Intravenous bags of Baxter’s 0.9% Sodium Chloride Injection, USP 500 mL and Lactated Ringer’s Injection, USP 500 mL from certain lots have the potential to leak when administered under pressure infusion due to a weak seal formation. Affected lots are…
AlertHealth professional risk communication | 2022-03-09
Health alert or recall Heparin Sodium and 0.9% Sodium Chloride Injection: leak in intravenous bag
Intravenous bag may be leaking in affected lot
RecallHealth product recall | 2022-03-07
Health alert or recall 0.9% Sodium Chloride Injection USP: Leaking solution bag
 Solution bags may be leaking in affected lot.
RecallHealth product recall | 2022-02-28
Health alert or recall Distribution of NUVAXOVID with English-only Vial and Carton Labels
NUVAXOVID was authorized by Health Canada on February 17, 2022. In order to provide earlier access to NUVAXOVID in the context of the global pandemic, Novavax, Inc. will distribute product vials, cartons and package inserts that are in English only for a…
AlertHealth professional risk communication | 2022-02-23
Health alert or recall Octagam 10% (Immune globulin intravenous, Human):Quality issue
Elevated reporting rate of hypersensitivity reactions in affected lot. 
RecallHealth product recall | 2022-02-23
Health alert or recall Odan Itraconazole: Out of specification
The assay is out of specification in the affected lot
RecallHealth product recall | 2022-02-23
Health alert or recall Auralgan: Impurities out of specification
Impurities could be out of specification in affected lots.
RecallHealth product recall | 2022-02-04
Health alert or recall BEOVU (brolucizumab) – Risk of Intraocular Inflammation, Retinal Vasculitis and/or Retinal Vascular Occlusion
An increased incidence of intraocular inflammation (IOI), including retinal vasculitis (RV) and retinal vascular occlusion (RO), was observed in patients who received BEOVU 6 mg with every 4 weeks (q4 week) dosing beyond the first 3 doses compared to…
AlertHealth professional risk communication | 2022-02-03
Health alert or recall Reddy-Dasatinib: out of specification
The dissolution is out of specification in the affected lot(s). 
RecallHealth product recall | 2022-01-31
Health alert or recall APO-AMITRIPTYLINE 10mg: NDMA impurity
Affected lots exceeds concentration limit for N-nitrosodimethylamine (NDMA) at the 36-month stability testing timepoint. 
RecallHealth product recall | 2022-01-26
Report a problem or mistake on this page
What was wrong?

You will not receive a reply. Telephone numbers and e-mail addresses will be removed.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.